{"id":62200,"date":"2025-11-13T19:03:22","date_gmt":"2025-11-13T18:03:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/"},"modified":"2025-11-13T19:03:22","modified_gmt":"2025-11-13T18:03:22","slug":"biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/","title":{"rendered":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics"},"content":{"rendered":"
\n

CAMBRIDGE, England–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (\u201cWatchmaker\u201d) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ product, or otherwise infringing on patents exclusively licensed by biomodal from Boston Children\u2019s Hospital through Children\u2019s Medical Center Corporation (\u201cCMCC\u201d), as outlined in the complaint.<\/p>\n

<\/a>
<\/a><\/p>\n

\nbiomodal is the exclusive licensee to patents invented by Professor Anjana Rao et al.<\/i>, relating to inter alia<\/i> uses of ten eleven translocation (TET) enzymes in methods to detect methylation and\/or hydroxymethylation. The patents asserted are U.S. Patent Nos. US 12,018,320, and US 12,291,742.<\/p>\n

\nbiomodal utilizes the patented \u2019Rao\u2019 technology in its core proprietary enzymes as well as its comprehensive duet multiomics solutions; duet evoC<\/a>, a 6-base genome technology that combines genetic and epigenetic information to provide single-base-resolution sequencing data that reveals standard four-base sequencing (A, C, G, and T) and distinguishes between 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) on the same DNA molecule, and duet +modC,<\/a> which delivers genetic and epigenetic methylation at single base resolution to provide a 5-base genome.<\/p>\n

\n\u201cThe favourable outcome of the claim construction hearing in our parallel litigation against NEB confirmed the seminal nature of Professor Rao\u2019s inventions and the broad interpretation of the claims to the use of TET,\u201d said Peter Fromen, CEO of biomodal. \u201cWe will continue to vigorously protect our IP rights, while safeguarding our customers\u2019 access to differentiated, comprehensive solutions that integrate assays and software to deliver unparalleled insights into biological systems.\u201d<\/p>\n

\nbiomodal\u2019s growing patent portfolio currently includes more than 25 U.S. and over 40 internationally issued patents, with more than 80 patent applications pending worldwide.<\/p>\n

\nAbout biomodal ltd.<\/b><\/p>\n

\nbiomodal is an omics-based life sciences technology and analytics company delivering products that bring the dynamism of our biology into focus. Our duet multiomics solutions enable multimodal information from a single, low input DNA sample without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, resolved sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer<\/a>, neurodegenerative disease<\/a>, and ageing.<\/p>\n

\nPlease visit biomodal.com<\/a> or follow the Company on LinkedIn linkedin.com\/company\/biomodal<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia contact:<\/p>\n

\nDonna McDade-Walker, PhD
\n
VP, Global Marketing & Product Management
\n
donna.mcdadewalker@biomodal.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, England–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (\u201cWatchmaker\u201d) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ product, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62200","6":"format-standard","7":"category-industry"},"yoast_head":"\nbiomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, England–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (\u201cWatchmaker\u201d) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ product, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T18:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics\",\"datePublished\":\"2025-11-13T18:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251113687796\\\/en\\\/2144580\\\/22\\\/biomodal_2C_fileformat.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/\",\"name\":\"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251113687796\\\/en\\\/2144580\\\/22\\\/biomodal_2C_fileformat.jpg\",\"datePublished\":\"2025-11-13T18:03:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251113687796\\\/en\\\/2144580\\\/22\\\/biomodal_2C_fileformat.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251113687796\\\/en\\\/2144580\\\/22\\\/biomodal_2C_fileformat.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/","og_locale":"en_US","og_type":"article","og_title":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend","og_description":"CAMBRIDGE, England–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (\u201cWatchmaker\u201d) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ product, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-13T18:03:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics","datePublished":"2025-11-13T18:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/","url":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/","name":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg","datePublished":"2025-11-13T18:03:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251113687796\/en\/2144580\/22\/biomodal_2C_fileformat.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biomodal-files-patent-infringement-lawsuit-against-watchmaker-genomics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"biomodal Files Patent Infringement Lawsuit Against Watchmaker Genomics"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62200"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62200\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}